Multiple immunoglobulin isotype switch after bispecific CAR-T cell therapy in multiple myeloma-A case report

Chenggong Li; Jiachen Liu; Jun Deng; Jia Xu; Yun Kang; Wenjing Luo; Lei Chen; Yu Hu; Heng Mei

doi:10.1111/bjh.18500

Multiple immunoglobulin isotype switch after bispecific CAR-T cell therapy in multiple myeloma-A case report

Br J Haematol. 2023 Feb;200(4):528-531. doi: 10.1111/bjh.18500. Epub 2022 Oct 9.

Authors

Chenggong Li^{1

2}, Jiachen Liu^{1

2}, Jun Deng^{1

2}, Jia Xu^{1

2}, Yun Kang^{1

2}, Wenjing Luo^{1

2}, Lei Chen^{1

2}, Yu Hu^{1

2}, Heng Mei^{1

2}

Affiliations

¹ Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China.

PMID: 36210354
DOI: 10.1111/bjh.18500

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Bispecific* / therapeutic use
B-Cell Maturation Antigen
Cell- and Tissue-Based Therapy
Humans
Immunoglobulin Isotypes
Immunotherapy, Adoptive
Multiple Myeloma* / therapy
Receptors, Chimeric Antigen*

Substances

Immunoglobulin Isotypes
Receptors, Chimeric Antigen
Antibodies, Bispecific
B-Cell Maturation Antigen

Publication types

MeSH terms

Substances

Grants and funding